1,5-Anhydroglucitol Is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus.

MLA

Ma, Xiaojing, et al. “1,5-Anhydroglucitol Is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus.” Diabetes Technology & Therapeutics, vol. 17, no. 5, May 2015, pp. 320–26. EBSCOhost, https://doi.org/10.1089/dia.2014.0346.

APA

Ma, X., Hao, Y., Hu, X., Luo, Y., Deng, Z., Zhou, J., Bao, Y., & Jia, W. (2015). 1,5-Anhydroglucitol Is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics, 17(5), 320–326. https://doi.org/10.1089/dia.2014.0346

Chicago

Ma, Xiaojing, Yaping Hao, Xiang Hu, Yuqi Luo, Zixuan Deng, Jian Zhou, Yuqian Bao, and Weiping Jia. 2015. “1,5-Anhydroglucitol Is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus.” Diabetes Technology & Therapeutics 17 (5): 320–26. doi:10.1089/dia.2014.0346.